Alterations in the gene expression of drug and arachidonic acid-metabolizing Cyp450 in the livers of controlled and uncontrolled insulin-dependent diabetic mice

References

• Corsino L Dhatariya K Umpierrez G Management of Diabetes and Hyperglycemia in Hospitalized Patients Endotext De Groot LJ Chrousos G Dungan K MA South Dartmouth 2000
   Google Scholar
• Ajlouni K Khader YS Batieha A Ajlouni H El-Khateeb M An increase in prevalence of diabetes mellitus in Jordan over 10 years J Diabetes Complications 2008 22 5 317 324 18413210
   PubMed Web of Science ®Google Scholar
• Albache N Al Ali R Rastam S Fouad FM Mzayek F Maziak W Epidemiology of Type 2 diabetes mellitus in Aleppo, Syria J Diabetes 2010 2 2 85 91 20923489
   PubMed Web of Science ®Google Scholar
• Engelgau MM Geiss LS Saaddine JB The evolving diabetes burden in the United States Ann Intern Med 2004 140 11 945 950 15172919
   PubMed Web of Science ®Google Scholar
• Obrosova IG Fathallah L Liu E Nourooz-Zadeh J Early oxidative stress in the diabetic kidney: effect of DL-alpha-lipoic acid Free Radic Biol Med 2003 34 2 186 195 12521600
   PubMed Web of Science ®Google Scholar
• Yue KK Chung WS Leung AW Cheng CH Redox changes precede the occurrence of oxidative stress in eyes and aorta, but not in kidneys of diabetic rats Life Sci 2003 73 20 2557 2570 12967680
   PubMed Web of Science ®Google Scholar
• American Diabetes Association Diagnosis and classification of diabetes mellitus Diabetes Care 2010 33 Suppl 1 S62 S69 20042775
   PubMed Web of Science ®Google Scholar
• Bhatt HB Smith RJ Fatty liver disease in diabetes mellitus Hepatobiliary Surg Nutr 2015 4 2 101 108 26005676
   PubMed Web of Science ®Google Scholar
• Mantovani A Targher G Type 2 diabetes mellitus and risk of hepatocellular carcinoma: spotlight on nonalcoholic fatty liver disease Ann Transl Med 2017 5 13 270 28758096
   PubMed Web of Science ®Google Scholar
• Irshaid Y Al-Hadidi H Abuirjeie M Acetylator phenotypes of Jordanian diabetics Eur J Clin Pharmacol 1992 43 6 621 623 1493843
   PubMed Web of Science ®Google Scholar
• Dostalek M Court MH Yan B Akhlaghi F Significantly reduced cytochrome P450 3A4 expression and activity in liver from humans with diabetes mellitus Br J Pharmacol 2011 163 5 937 947 21323901
   PubMed Web of Science ®Google Scholar
• Dostalek M Court MH Hazarika S Akhlaghi F Diabetes mellitus reduces activity of human UDP-glucuronosyltransferase 2B7 in liver and kidney leading to decreased formation of mycophenolic acid acylglucuronide metabolite Drug Metab Dispos 2011 39 3 448 455 21123165
   PubMed Web of Science ®Google Scholar
• Lee JH Yang SH Oh JM Lee MG Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus J Pharm Pharmacol 2010 62 1 1 23 20722995
   PubMed Web of Science ®Google Scholar
• Elshenawy OH Shoieb SM Mohamed A El-Kadi AO Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic Target Pharmaceutics 2017 9 1 9
   Web of Science ®Google Scholar
• Leclercq IA Farrell GC Field J CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis J Clin Invest 2000 105 8 1067 1075 10772651
   PubMed Web of Science ®Google Scholar
• Lukaszewicz KM Lombard JH Role of the CYP4A/20-HETE pathway in vascular dysfunction of the Dahl salt-sensitive rat Clin Sci 2013 124 12 695 700 23438293
   PubMed Web of Science ®Google Scholar
• Pass GJ Becker W Kluge R Effect of hyperinsulinemia and type 2 diabetes-like hyperglycemia on expression of hepatic cytochrome p450 and glutathione s-transferase isoforms in a New Zealand obese-derived mouse backcross population J Pharmacol Exp Ther 2002 302 2 442 450 12130701
   PubMed Web of Science ®Google Scholar
• Ahmed S Zhou Z Zhou J Chen SQ Pharmacogenomics of Drug Metabolizing Enzymes and Transporters: Relevance to Precision Medicine Genomics Proteomics Bioinformatics 2016 14 5 298 313 27729266
   PubMed Web of Science ®Google Scholar
• Canadian Council on Animal Care Guide to the care and use of experimental animals Canadian Council on Animal Care Ottawa, Ont 1980
   Google Scholar
• Guo T Mao Y Li H Characterization of the gene expression profile of heterozygous liver-specific glucokinase knockout mice at a young age Biomed Pharmacother 2012 66 8 587 596 23085254
   PubMed Web of Science ®Google Scholar
• Oliveira WH Nunes AK França ME Effects of metformin on inflammation and short-term memory in streptozotocin-induced diabetic mice Brain Res 2016 1644 149 160 27174003
   PubMed Web of Science ®Google Scholar
• Livak KJ Schmittgen TD Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method Methods 2001 25 4 402 408 11846609
   PubMed Web of Science ®Google Scholar
• Jarrar YB Shin JG Lee SJ Expression of arachidonic acid-metabolizing cytochrome P450s in human megakaryocytic Dami cells In Vitro Cell Dev Biol Anim 2013 49 7 492 500 23722412
   PubMed Web of Science ®Google Scholar
• Jarrar YB Balasmeh AA Jarrar W Sequence analysis of the N-acetyl-transferase 2 gene (NAT2) among Jordanian volunteers Libyan J Med 2018 13 1 1408381 29173142
   PubMed Web of Science ®Google Scholar
• King AJ The use of animal models in diabetes research Br J Pharmacol 2012 166 3 877 894 22352879
   PubMed Web of Science ®Google Scholar
• Cheng Y Kang H Shen J Beta-cell regeneration from vimentin+/ MafB+ cells after STZ-induced extreme beta-cell ablation Sci Rep 2015 5 11703 26129776
   PubMed Web of Science ®Google Scholar
• Damasceno DC Netto AO Iessi IL Streptozotocin-induced diabetes models: pathophysiological mechanisms and fetal outcomes Biomed Res Int 2014 2014 819065 24977161
   PubMed Web of Science ®Google Scholar
• Kume E Fujimura H Matsuki N Hepatic changes in the acute phase of streptozotocin (SZ)-induced diabetes in mice Exp Toxicol Pathol 2004 55 6 467 480 15384252
   PubMedGoogle Scholar
• Cobbina E Akhlaghi F Non-alcoholic fatty liver disease (NAFLD) -pathogenesis, classification, and effect on drug metabolizing enzymes and transporters Drug Metab Rev 2017 49 2 197 211 28303724
   PubMed Web of Science ®Google Scholar
• Palatini P de Martin S Pharmacokinetic drug interactions in liver disease: An update World J Gastroenterol 2016 22 3 1260 1278 26811663
   PubMed Web of Science ®Google Scholar
• Elbekai RH Korashy HM El-Kadi AO The effect of liver cirrhosis on the regulation and expression of drug metabolizing enzymes Curr Drug Metab 2004 5 2 157 167 15078193
   PubMed Web of Science ®Google Scholar
• Higuchi S Wu R Zhou M Ravikumar TS Wang P Downregulation of hepatic cytochrome P-450 isoforms and PPAR-gamma: their role in hepatic injury and proinflammatory responses in a double-hit model of hemorrhage and sepsis J Surg Res 2007 137 1 46 52 17101152
   PubMed Web of Science ®Google Scholar
• Kim JH Nam WS Kim SJ Mechanism Investigation of Rifam-picin-Induced Liver Injury Using Comparative Toxicoproteomics in Mice Int J Mol Sci 2017 18 7 E1417 28671602
   PubMed Web of Science ®Google Scholar
• Klein M Thomas M Hofmann U A systematic comparison of the impact of inflammatory signaling on absorption, distribution, metabolism, and excretion gene expression and activity in primary human hepatocytes and HepaRG cells Drug Metab Dispos 2015 43 2 273 283 25480923
   PubMed Web of Science ®Google Scholar
• Loria P Lonardo A Anania F Liver and diabetes. A vicious circle Hepatol Res 2013 43 1 51 64 23332087
   PubMed Web of Science ®Google Scholar
• Almazroo OA Miah MK Venkataramanan R Drug Metabolism in the Liver Clin Liver Dis 2017 21 1 1 20 27842765
   PubMed Web of Science ®Google Scholar
• Oltmanns D Dennin DE Pentz R Siegers CP Antipyrine clearance as a measure of drug metabolism in patients with diabetes mellitus Z Gastroenterol 1984 22 10 598 601 6506825
   PubMed Web of Science ®Google Scholar
• Kudo T Toda T Ushiki T Differences in the pharmacokinetics of Cyp3a substrates in TSOD and streptozotocin-induced diabetic mice Xenobiotica 2010 40 4 282 290 20163193
   PubMed Web of Science ®Google Scholar
• Jarrar YB Cha EY Seo KA Determination of major UDP-glucuronosyltransferase enzymes and their genotypes responsible for 20-HETE glucuronidation J Lipid Res 2014 55 11 2334 2342 25249502
   PubMed Web of Science ®Google Scholar
• Alsaad AM Zordoky BN El-Sherbeni AA El-Kadi AO Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats Drug Metab Dispos 2012 40 11 2126 2135 22867862
   PubMed Web of Science ®Google Scholar
• de Gregori S de Gregori M Ranzani GN Morphine metabolism, transport and brain disposition Metab Brain Dis 2012 27 1 1 5 22193538
   PubMed Web of Science ®Google Scholar
• Dean L Irinotecan Therapy and UGT1A1 Genotype Medical Genetics Summaries Pratt V McLeod H Dean L Malheiro A Rubinstein W MD Bethesda 2012
   Google Scholar
• Hakooz N Jarrar YB Zihlif M Effects of the genetic variants of organic cation transporters 1 and 3 on the pharmacokinetics of metfor-min in Jordanians Drug Metab Pers Ther 2017 32 3 157 162 28862982
   PubMedGoogle Scholar
• Grover B Buckley D Buckley AR Cacini W Reduced expression of organic cation transporters rOCT1 and rOCT2 in experimental diabetes J Pharmacol Exp Ther 2004 308 3 949 956 14718608
   PubMed Web of Science ®Google Scholar
• Mastaitis JW Wurmbach E Cheng H Sealfon SC Mobbs CV Acute induction of gene expression in brain and liver by insulin-induced hypoglycemia Diabetes 2005 54 4 952 958 15793232
   PubMed Web of Science ®Google Scholar
• Davidson MD Ballinger KR Khetani SR Long-term exposure to abnormal glucose levels alters drug metabolism pathways and insulin sensitivity in primary human hepatocytes Sci Rep 2016 6 28178 27312339
   PubMed Web of Science ®Google Scholar